Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE−/− Mice Using VCAM-1–Specific, 99mTc-Labeled Peptidic Sequences

Julien Dimastromatteo, Alexis Broisat, Pascale Perret, Mitra Ahmadi, Didier Boturyn, Pascal Dumy, Daniel Fagret, Laurent M. Riou and Catherine Ghezzi
Journal of Nuclear Medicine August 2013, 54 (8) 1442-1449; DOI: https://doi.org/10.2967/jnumed.112.115675
Julien Dimastromatteo
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexis Broisat
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Perret
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitra Ahmadi
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Boturyn
2UJF-Grenoble 1, Grenoble, France; and
3Département de Chimie Moléculaire, UMR CNRS-UJF 5250, Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Dumy
2UJF-Grenoble 1, Grenoble, France; and
3Département de Chimie Moléculaire, UMR CNRS-UJF 5250, Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Fagret
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent M. Riou
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Ghezzi
1INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France
2UJF-Grenoble 1, Grenoble, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Histologic (hematoxylin, erythrosine, and safran) and immunohistologic staining of VCAM-1 and Mac-2 expression in ApoE−/− mouse carotid vessels. Histochemistry and immunohistochemistry were performed on adjacent transverse sections of atherosclerotic lesions from ligated left carotid arteries (A–E), with magnifications centered on intimal and adventitial areas (F–J and K–O, respectively) and on nonligated left carotid arteries from sham-operated ApoE−/− animals (P–T) and on contralateral, right, carotid arteries (U–Y). Positive VCAM-1 and Mac-2 immunostaining was observed in atherosclerotic lesions developing at site of left carotid artery ligation but not in vessels from sham-operated animals and right carotid arteries. Specificity of immunostaining was assessed by performing control experiments in absence of VCAM-1– and Mac-2–specific primary antibodies (without VCAM-1 Ab and without MAC-2 Ab). Ab = antibody; HES = hematoxylin, erythrosine, and safran; w/o = without.*Vessel lumen.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Left-to-right carotid (A) and left carotid-to-blood (B) activity ratios of 99mTc-labeled peptidic sequences as determined by γ-well counting at 180 min after intravenous tracer injection. mis. = mismatch. *P < 0.05 vs. 99mTc-B2702p. †P < 0.05 vs. 99mTc-B2702p1 mismatch.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Time–activity curves of 99mTc-B2702p1 in blood and left and right carotid arteries at 15, 60, and 180 min after intravenous injection of tracer.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    (A) Representative planar images of ApoE−/− mouse with left carotid artery ligation at 180 min after injection of 99mTc-B2702p1, 99mTc-B2702p1 mismatch, and 99mTc-B2702p; corresponding left-to-right carotid tracer activity ratios are indicated in parentheses. (B) 99mTc-B2702p1, 99mTc-B2702p1 mismatch, and 99mTc-B2702p left-to-right carotid activity ratios from in vivo planar image quantification. *P < 0.05 vs. 99mTc-B2702p. †P < 0.05 vs. 99mTc-B2702p1 mismatch. mis = mismatch.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    (A) Representative pinhole SPECT image of 99mTc-B2702p1 and 99mTc-B2702p activity at level of atherosclerotic lesion developing at site of left carotid artery ligation in ApoE−/− mouse. Corresponding left-to-right carotid tracer activity ratios are indicated in parentheses. (B) Left and right 99mTc-B2702p1 (left) and 99mTc-B2702p (right) carotid activities from in vivo pinhole SPECT image quantification. *P < 0.05 vs. right carotid tracer activity.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Anisotropy values from [F]-B2702p1 in presence of increasing concentrations of recombinant human VCAM-1. Results from control experiments performed in absence of VCAM-1 and in presence of nonspecific target bovine serum albumin are shown in inset.

Tables

  • Figures
    • View popup
    TABLE 1

    Peptidic Sequence, Radiochemical Purity, and Urinary Stability of 99mTc-B2702p1-20 Peptides

    TracerPeptidic sequenceRCP (%)Stability (%)
    99mTc-B2702pH2N-HGR ENL RIA LRY-COOH9093
    99mTc-B2702p1H2N-HGR ANL RIL ARY-COOH9294
    99mTc-B2702p1 mismatchH2N- HGL RAY IRA RNL-COOH9089
    99mTc-B2702p2H2N-HGR ENL AIL ARY-COOH9596
    99mTc-B2702p3H2N-HGR ENL RIL ARA-COOH9783
    99mTc-B2702p4H2N-HGR ENL RIL AAY-COOH9592
    99mTc-B2702p5H2N-HGR ENL RIL ARY-COOH50N/D
    99mTc-B2702p6H2N-HGR ENA RIL ARY-COOH9395
    99mTc-B2702p7H2N-HGA ENL RIL ARY-COOH9550
    99mTc-B2702p8H2N-HGR ENL RIA ARY-COOH8084
    99mTc-B2702p9H2N-HGR EAL RIL ARY-COOH9597
    99mTc-B2702p10H2N-HGR ENL RIL ARY-COOH9599
    99mTc-B2702p11H2N-HGA ENL RIA LRY-COOH9782
    99mTc-B2702p12H2N-HGR ANL RIA LRY-COOH8880
    99mTc-B2702p13H2N-HGR EAL RIA LRY-COOH9679
    99mTc-B2702p14H2N-HGR ENA RIA LRY-COOH9676
    99mTc-B2702p15H2N-HGR ENL AIA LRY-COOH9685
    99mTc-B2702p16H2N-HGR ENL RAA LRY-COOH9170
    99mTc-B2702p17H2N-HGR ENL RIA LAY-COOH9080
    99mTc-B2702p18H2N-HGR ENL RIA LRA-COOH8881
    99mTc-B2702p19H2N-HGR ANL RIL ARA-COOH8879
    99mTc-B2702p20H2N-HGR ANL RIL AAY-COOH9278
    • N/D = not determined; RCP = radiochemical purity.

    • View popup
    TABLE 2

    Biodistribution of 99mTc-B2702p1-20 at 180 Minutes After Injection in ApoE−/− Mice with Left Carotid Artery Ligation

    TracerHeartAortaLungLiverSpleenKidneyFatMuscleBloodThyroidL. carotidR. carotid
    99mTc-B2702p1.5 ± 0.12.7 ± 0.43.9 ± 0.410.6 ± 2.62.2 ± 0.369.0 ± 13.01.0 ± 0.21.2 ± 0.25.7 ± 0.69.7 ± 3.02.4 ± 0.41.8 ± 0.3
    99mTc-B2702p10.3 ± 0.10.5 ± 0.10.8 ± 0.13.1 ± 0.61.6 ± 0.74.6 ± 0.50.2 ± 0.00.1 ± 0.00.9 ± 0.2†0.7 ± 0.21.3 ± 0.4*0.5 ± 0.1†
    99mTc-B2702p1 mismatch0.7 ± 0.21.7 ± 0.71.7 ± 0.422.1 ± 5.90.8 ± 0.115.5 ± 4.20.5 ± 0.20.5 ± 0.12.4 ± 0.81.1 ± 0.41.2 ± 0.61.2 ± 0.6
    99mTc-B2702p20.3 ± 0.10.9 ± 0.60.8 ± 0.32.7 ± 0.31.4 ± 0.413.4 ± 1.90.3 ± 0.20.2 ± 0.10.9 ± 0.3†1.3 ± 0.10.5 ± 0.2†0.3 ± 0.1†
    99mTc-B2702p30.4 ± 0.10.7 ± 0.20.9 ± 0.24.2 ± 0.60.8 ± 0.233.1 ± 0.70.3 ± 0.10.2 ± 0.11.3 ± 0.3†0.6 ± 0.10.5 ± 0.1†0.4 ± 0.1†
    99mTc-B2702p40.3 ± 0.10.6 ± 0.30.6 ± 0.24.7 ± 0.90.6 ± 0.226.2 ± 5.10.2 ± 0.10.2 ± 0.10.9 ± 0.4†0.6 ± 0.20.7 ± 0.4†0.2 ± 0.1†
    99mTc-B2702p60.3 ± 0.00.6 ± 0.00.7 ± 0.05.9 ± 1.00.5 ± 0.08.2 ± 0.70.2 ± 0.00.1 ± 0.01.1 ± 0.1†1.5 ± 0.30.5 ± 0.1†0.4 ± 0.2†
    99mTc-B2702p70.4 ± 0.00.7 ± 0.10.9 ± 0.18.2 ± 0.41.0 ± 0.38.0 ± 1.30.2 ± 0.00.2 ± 0.01.3 ± 0.1†1.9 ± 0.70.4 ± 0.2†0.4 ± 0.2†
    99mTc-B2702p80.3 ± 0.10.7 ± 0.10.9 ± 0.16.9 ± 1.60.8 ± 0.220.6 ± 10.80.2 ± 0.10.2 ± 0.11.2 ± 0.3†1.6 ± 0.60.4 ± 0.1†0.2 ± 0.1†
    99mTc-B2702p90.1 ± 0.00.3 ± 0.00.4 ± 0.02.1 ± 0.10.4 ± 0.12.2 ± 0.20.1 ± 0.00.1 ± 0.00.4 ± 0.0†0.4 ± 0.00.1 ± 0.0†0.1 ± 0.0†
    99mTc-B2702P100.5 ± 0.30.3 ± 0.00.4 ± 0.12.8 ± 0.50.4 ± 0.123.6 ± 3.70.1 ± 0.00.1 ± 0.00.4 ± 0.0†0.3 ± 0.00.1 ± 0.0†0.4 ± 0.2†
    99mTc-B2702p111.8 ± 0.12.7 ± 0.13.6 ± 0.310.8 ± 0.62.9 ± 0.119.2 ± 0.81.5 ± 0.30.6 ± 0.16.7 ± 0.414.2 ± 6.92.1 ± 0.31.9 ± 0.7
    99mTc-B2702p120.4 ± 0.12.8 ± 0.94.2 ± 1.55.5 ± 0.63.1 ± 0.236.9 ± 11.40.8 ± 0.10.8 ± 0.44.4 ± 1.28.8 ± 2.82.1 ± 0.91.4 ± 0.4
    99mTc-B2702p131.6 ± 0.32.3 ± 0.33.3 ± 0.48.0 ± 0.62.9 ± 0.422.7 ± 7.50.8 ± 0.30.5 ± 0.15.9 ± 0.511.0 ± 3.21.7 ± 0.31.8 ± 0.4
    99mTc-B2702p142.5 ± 0.73.2 ± 0.65.7 ± 1.412.7 ± 2.43.7 ± 1.034.6 ± 1.90.8 ± 0.10.7 ± 0.210.7 ± 2.215.9 ± 2.62.2 ± 0.22.2 ± 0.2
    99mTc-B2702p154.5 ± 0.35.2 ± 0.111.2 ± 0.718.1 ± 0.76.4 ± 0.234.0 ± 4.41.6 ± 0.71.2 ± 0.116.4 ± 0.96.3 ± 1.13.3 ± 0.71.9 ± 0.5
    99mTc-B2702p160.3 ± 0.00.6 ± 0.10.9 ± 0.13.4 ± 0.41.2 ± 0.198.9 ± 18.10.4 ± 0.10.2 ± 0.01.0 ± 0.1†1.7 ± 0.20.4 ± 0.0†0.4 ± 0.2†
    99mTc-B2702p170.4 ± 0.10.6 ± 0.21.2 ± 0.53.5 ± 1.21.6 ± 0.785.3 ± 25.70.3 ± 0.10.3 ± 0.21.3 ± 0.4†2.8 ± 0.40.4 ± 0.1†0.2 ± 0.1†
    99mTc-B2702p180.5 ± 0.12.5 ± 0.43.2 ± 0.56.3 ± 1.52.3 ± 0.763.9 ± 17.21.2 ± 0.50.7 ± 0.05.9 ± 1.018.8 ± 2.72.0 ± 0.2*1.0 ± 0.1†
    99mTc-B2702p190.5 ± 0.10.9 ± 0.31.3 ± 0.25.5 ± 0.51.5 ± 0.115.2 ± 6.00.2 ± 0.00.3 ± 0.02.0 ± 0.5†1.9 ± 1.50.7 ± 0.1†1.1 ± 0.5
    99mTc-B2702p200.6 ± 0.21.4 ± 0.41.2 ± 0.36.1 ± 1.11.0 ± 0.411.1 ± 2.00.2 ± 0.10.2 ± 0.12.2 ± 0.6†0.5 ± 0.20.9 ± 0.1†1.2 ± 0.8
    • Data are mean ± SE %ID/g. *P < 0.05 vs. right carotid. †P < 0.05 vs. 99mTc-B2702p.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (8)
Journal of Nuclear Medicine
Vol. 54, Issue 8
August 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE−/− Mice Using VCAM-1–Specific, 99mTc-Labeled Peptidic Sequences
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE−/− Mice Using VCAM-1–Specific, 99mTc-Labeled Peptidic Sequences
Julien Dimastromatteo, Alexis Broisat, Pascale Perret, Mitra Ahmadi, Didier Boturyn, Pascal Dumy, Daniel Fagret, Laurent M. Riou, Catherine Ghezzi
Journal of Nuclear Medicine Aug 2013, 54 (8) 1442-1449; DOI: 10.2967/jnumed.112.115675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE−/− Mice Using VCAM-1–Specific, 99mTc-Labeled Peptidic Sequences
Julien Dimastromatteo, Alexis Broisat, Pascale Perret, Mitra Ahmadi, Didier Boturyn, Pascal Dumy, Daniel Fagret, Laurent M. Riou, Catherine Ghezzi
Journal of Nuclear Medicine Aug 2013, 54 (8) 1442-1449; DOI: 10.2967/jnumed.112.115675
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Contrast-Enhanced, Molecular Imaging of Vascular Inflammation in the Mouse Model by Simultaneous PET/MRI
  • In Vivo Translation of the CIRPI System: Revealing Molecular Pathology of Rabbit Aortic Atherosclerotic Plaques
  • Molecular imaging of atherosclerosis: spotlight on Raman spectroscopy and surface-enhanced Raman scattering
  • Scintillating Balloon-Enabled Fiber-Optic System for Radionuclide Imaging of Atherosclerotic Plaques
  • PET/CT Imaging of Chemokine Receptor CCR5 in Vascular Injury Model Using Targeted Nanoparticle
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

Keywords

  • VCAM-1
  • Molecular imaging
  • vulnerable atherosclerotic plaque
SNMMI

© 2025 SNMMI

Powered by HighWire